cea12235-sup-0001-Fig1.pdfapplication/PDF172KFigure S1. The mean (background subtracted) frequency of antigen-specific IFNγ-secreting T cells before and after treatment with anti-OX40L MAb. PBMC were isolated before (Day 5) and after (Day 112) treatment with placebo or anti-OX40L MAb, and cultured with sensitizing allergen and recall antigen.
cea12235-sup-0002-Fig2.pptxapplication/pptx121KFigure S2. The mean (SEM) number of mDC1 (top panel), mDC2 (middle panel) and pDCs (bottom panel) following treatment with placebo (open bars) and anti-OX40L MAb (solid bars) measured post-treatment Days 55 and 112 (pre-allergen) and 57 and 114 (24 hrs after allergen challenge).
cea12235-sup-0003-SuppInfo.docxWord document53KData S1. Additional methods and results.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.